![Priya Marreddy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Priya Marreddy
Direttore Tecnico/Scientifico/R&S presso CONTEXT THERAPEUTICS INC.
Profilo
Priya Marreddy is currently the Vice President-Clinical Operations at Context Therapeutics, Inc. Previously, she worked as the Head-Clinical Operations at Cornerstone Pharmaceuticals, Inc. She completed her graduate degree at the University of Pennsylvania and her undergraduate degree at George Washington University.
Posizioni attive di Priya Marreddy
Società | Posizione | Inizio |
---|---|---|
CONTEXT THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2022 |
Precedenti posizioni note di Priya Marreddy
Società | Posizione | Fine |
---|---|---|
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Priya Marreddy
George Washington University | Undergraduate Degree |
University of Pennsylvania | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CONTEXT THERAPEUTICS INC. | Health Technology |
Aziende private | 1 |
---|---|
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Priya Marreddy